Substance Name: Ensituximab [USAN:INN]
RN: 1092658-06-4
UNII: F988K568V2
Note
- Targets an MUC5AC variant for treatment of refractory pancreatic and colorectal cancer.
Molecular Formula
- C6342-H9800-N1678-O1985-S46
Classification Code
- Treatment of Cancer
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Ensituximab [USAN:INN]
Synonyms
- Ensituximab
- Immunoglobulin G1, anti-(human mucin-5AC (tracheobronchial mucin, gastric mucin, Lewis B blood group antigen), colorectal and pancreatic carcinoma-associated antigen); human-mouse chimeric monoclonal NPC-1C gamma1 heavy chain (216-213')- disulfide with human-mouse chimeric monoclonal NPC-1C kappa light chain dimer (222- 222'':225-225'')-bisdisulfide
- NPC-1C
- UNII-F988K568V2
Systematic Name
- Immunoglobulin G1, anti-(colorectal and pancreatic carcinoma-associated antigen) (human-mouse monoclonal NPC-1C heavy chain), disulfide with human-mouse monoclonal NPC-1C kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1092658-06-4
FDA UNII
- F988K568V2
System Generated Number
- 1092658064